著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Naiyer A Rizvi and Julien Mazières and David Planchard and Thomas E Stinchcombe and Grace K Dy and Scott J Antonia and Leora Horn and Hervé Lena and Elisa Minenza and Bertrand Mennecier and Gregory A Otterson and Luis T Campos and David R Gandara and Benjamin P Levy and Suresh G Nair and Gérard Zalcman and Jürgen Wolf and Pierre-Jean Souquet and Editta Baldini and Federico Cappuzzo and Christos Chouaid and Afshin Dowlati and Rachel Sanborn and Ariel Lopez-Chavez and Christian Grohe and Rudolf M Huber and Christopher T Harbison and Christine Baudelet and Brian J Lestini and Suresh S Ramalingam,"Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial",The Lancet Oncology,1470-2045,Elsevier BV,2015-03,16,3,257-265,https://cir.nii.ac.jp/crid/1361699995833161472,https://doi.org/10.1016/s1470-2045(15)70054-9